Literature DB >> 24900592

Identification of 1-[4-Benzyloxyphenyl)-but-3-enyl]-1H-azoles as New Class of Antitubercular and Antimicrobial Agents.

Namrata Anand1, K K G Ramakrishna1, Munna P Gupt1, Vinita Chaturvedi1, Shubhra Singh1, Kishore K Srivastava1, Prapunjika Sharma1, Niyati Rai1, Ravishankar Ramachandran1, A K Dwivedi1, Varsha Gupta1, Brijesh Kumar1, Smriti Pandey1, Praveen K Shukla1, Shailandra K Pandey1, Jawahar Lal1, Rama Pati Tripathi1.   

Abstract

A series of 1-[(4-benzyloxyphenyl)-but-3-enyl]-1H-azoles has been identified as potent antitubercular agents against Mycobacterium tuberculosis. Synthesis of compounds involved acid catalyzed ring-opening of cyclopropyl ring of phenyl cyclopropyl methanols followed by nucleophilic attack of the azoles on the carbocation intermediates. Several of the compounds 26, 34, and 36 exhibited significant antitubercular activities with MIC value as low as 1.56, 1.56, and 0.61 μg/mL, respectively, comparable to many standard drugs. These compounds were also screened against other strains of bacteria and fungi, and few of them showed good antifungal activity against A. fumigatus, responsible for lung infection.

Entities:  

Keywords:  Antitubercular agents; Mycobacterium tuberculosis; azoles; cyclopropyl methanols

Year:  2013        PMID: 24900592      PMCID: PMC4027561          DOI: 10.1021/ml4002248

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  17 in total

Review 1.  Drug-drug interactions and tolerance in combining antituberculosis and antiretroviral therapy.

Authors:  Giovanni Di Perri; Diego Aguilar Marucco; Alessandra Mondo; Daniel Gonzalez de Requena; Sabrina Audagnotto; Federico Gobbi; Stefano Bonora
Journal:  Expert Opin Drug Saf       Date:  2005-09       Impact factor: 4.250

2.  Synthesis and optimization of antitubercular activities in a series of 4-(aryloxy)phenyl cyclopropyl methanols.

Authors:  Surendra S Bisht; Namrata Dwivedi; Vinita Chaturvedi; Namrata Anand; Mridul Misra; Rahul Sharma; Brijesh Kumar; Richa Dwivedi; Shyam Singh; Sudhir Kumar Sinha; Versha Gupta; P R Mishra; Anil K Dwivedi; Rama P Tripathi
Journal:  Eur J Med Chem       Date:  2010-10-20       Impact factor: 6.514

3.  An efficient synthesis of aryloxyphenyl cyclopropyl methanones: a new class of anti-mycobacterial agents.

Authors:  Namrata Dwivedi; Neetu Tewari; V K Tiwari; Vinita Chaturvedi; Y K Manju; A Srivastava; A Giakwad; S Sinha; R P Tripathi
Journal:  Bioorg Med Chem Lett       Date:  2005-10-15       Impact factor: 2.823

4.  Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance.

Authors:  A H Diacon; P R Donald; A Pym; M Grobusch; R F Patientia; R Mahanyele; N Bantubani; R Narasimooloo; T De Marez; R van Heeswijk; N Lounis; P Meyvisch; K Andries; D F McNeeley
Journal:  Antimicrob Agents Chemother       Date:  2012-03-05       Impact factor: 5.191

5.  Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines.

Authors:  Marina Protopopova; Colleen Hanrahan; Boris Nikonenko; Rowena Samala; Ping Chen; Jackie Gearhart; Leo Einck; Carol A Nacy
Journal:  J Antimicrob Chemother       Date:  2005-09-19       Impact factor: 5.790

Review 6.  Physiological parameters in laboratory animals and humans.

Authors:  B Davies; T Morris
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

7.  Molecular characterization of Mycobacterium tuberculosis isolates from North Indian patients with extrapulmonary tuberculosis.

Authors:  Manimuthu Mani Sankar; Jitendra Singh; Selvaraj Cynthiya Angelin Diana; Sarman Singh
Journal:  Tuberculosis (Edinb)       Date:  2012-11-07       Impact factor: 3.131

8.  Altered expression profile of mycobacterial surface glycopeptidolipids following treatment with the antifungal azole inhibitors econazole and clotrimazole.

Authors:  Adeline Burguière; Paul G Hitchen; Lynn G Dover; Anne Dell; Gurdyal S Besra
Journal:  Microbiology       Date:  2005-06       Impact factor: 2.777

Review 9.  Cytochromes P450: novel drug targets in the war against multidrug-resistant Mycobacterium tuberculosis.

Authors:  A W Munro; K J McLean; K R Marshall; A J Warman; G Lewis; O Roitel; M J Sutcliffe; C A Kemp; S Modi; N S Scrutton; D Leys
Journal:  Biochem Soc Trans       Date:  2003-06       Impact factor: 5.407

10.  Synthesis and evaluation of small libraries of triazolylmethoxy chalcones, flavanones and 2-aminopyrimidines as inhibitors of mycobacterial FAS-II and PknG.

Authors:  Namrata Anand; Priyanka Singh; Anindra Sharma; Sameer Tiwari; Vandana Singh; Diwakar K Singh; Kishore K Srivastava; B N Singh; Rama Pati Tripathi
Journal:  Bioorg Med Chem       Date:  2012-07-14       Impact factor: 3.641

View more
  1 in total

Review 1.  Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review.

Authors:  Khalid Karrouchi; Smaail Radi; Youssef Ramli; Jamal Taoufik; Yahia N Mabkhot; Faiz A Al-Aizari; M'hammed Ansar
Journal:  Molecules       Date:  2018-01-12       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.